Reactions Weekly

, Volume 1196, Issue 1, pp 4–4 | Cite as

The US FDA has issued an early communication about its ongoing safety review of abacavir [Ziagen] and didanosine [Videx]

Media release
  • 10 Downloads

Keywords

Public Health Adverse Event Data Collection Heart Disease Reverse Transcriptase 

REFERENCE

  1. 1.
    FDA.Early Communication about an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine). Media Release: 27 Mar 2008. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations